Results 91 to 100 of about 92,350 (272)

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports

open access: yes, 2011
Mahmud Mahamid1,3, Kalman Paz3, Rifaat Safadi1,21Liver Unit, Holy Family Hospital, Nazareth, Israel; 2Hadassah Medical Center, 3Shaare Zedek Medical Center, Jerusalem, IsraelAbstract: Elevation of liver enzymes in patients with rheumatoid arthritis ...
Paz K, Safadi R, Mahamid M
core  

Fast Infusion of TOCILIZUMAB in Rheumatoid Arthritis is Well Tolerated

open access: yes, 2014
Fast infusion of tocilizumab in rheumatoid arthritis is well toleratedFast infusion of tocilizumab in rheumatoid arthritis is well toleratedEULAR-SCIE ...
Johansen, P. B.   +14 more
core   +1 more source

An Oral Antiviral Combination Against Severe COVID‐19 Enabled by the Synergistic Mechanisms of Action of Auranofin and Remdesivir

open access: yesAdvanced Science, EarlyView.
FDA‐approved anti‐inflammatory drug Auranofin inhibits SARS‐CoV‐2 replication by inhibiting viral Main protease activity and Spike processing required for viral entry. It shows strong synergy with nucleoside analogue Remdesivir, due to non‐overlapping mechanisms.
Oyahida Khatun   +13 more
wiley   +1 more source

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis

open access: yes, 2012
Miho Murakami,1 Minako Tomiita,2,3 Norihiro Nishimoto11Laboratory of Immune Regulation, Wakayama Medical University, Wakayama, 2Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, 3Department of Allergy and Rheumatology, Chiba
Nishimoto N, Tomiita M, Murakami M
core  

A Case of Organizing Pneumonia Induced by Tocilizumab [PDF]

open access: yes, 2011
A 66-year-old woman rheumatoid arthritis was treated with methotrexate and tocilizumab. Chest radiography revealed bilateral consolidation of an upper lesion in the lung.
Kayoko Ikegawa   +9 more
core   +1 more source

‐19‐induced refractory status epilepticus by tocilizumab

open access: yes, 2022
BACKGROUND AND PURPOSE: COVID‐19 is a novel infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in which neurological complications have been increasingly recognized.
Delil, Sakir   +9 more
core   +1 more source

Comparison of drug retention rates between TNF inhibitors and tocilizumab for Takayasu arteritis: a multicenter retrospective study

open access: yesImmunological Medicine
Objective. We compared the drug retention rate of tumor necrosis factor (TNF) inhibitors (TNFi) and tocilizumab in Takayasu arteritis (TAK) as an index of balance between effectiveness and safety in a real-world setting. Method.
Takahiro Sugiyama   +10 more
doaj   +1 more source

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm   +2 more
wiley   +1 more source

Case reports Juvenile idiopathic arthritis complicated by amyloidosis with secondary nephrotic syndrome – effective treatment with tocilizumab

open access: yes, 2015
A case report of a boy with juvenile idiopathic arthritis since the age of 2 years, generalized onset, complicated by nephrotic syndrome due to secondary type A amyloidosis is presented.
Małgorzata Kwiatkowska   +2 more
core   +1 more source

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya [PDF]

open access: yes, 2022
Introduction: From the first case of SARS-Co-2 in Wuhan, China, to the virus being declared as a pandemic in March 2020, the world has witnessed morbidity and mortality on a global scale.
Shah, Reena   +4 more
core  

Home - About - Disclaimer - Privacy